Anoro Ellipta recall
ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 blisters total), Rx Only, Manufactured…
Why was Anoro Ellipta recalled?
Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 7Y9S. Exp June 2025
- Product
- ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 blisters total), Rx Only, Manufactured…
- Recalling firm
- GlaxoSmithKline LLC
- Quantity
- 67,508 inhalers
- Distribution
- Distributed Nationwide in the USA and Puerto Rico.
- Recall date
- January 3, 2024
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)